The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Cancer remains an elusive, highly complex disease and a global burden. Constant change by acquired mutations and metabolic reprogramming contribute to the high inter- and intratumor heterogeneity of malignant cells, their selective growth advantage, and their resistance to anticancer therapies. In the modern era of integrative biomedicine, realizin...
Alternative Titles
Full title
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a7545b0342bc451a81b3100d26fa395a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7545b0342bc451a81b3100d26fa395a
Other Identifiers
ISSN
2076-3921
E-ISSN
2076-3921
DOI
10.3390/antiox9111151
